Abate Kristin
Karyopharm Therapeutics Inc. · Chief Accounting Officer
Abate Kristin is listed in filings as Chief Accounting Officer at Karyopharm Therapeutics Inc.. This profile follows SEC Form 4 activity through May 15, 2026, including sale activity. Recent filings connect the profile to Karyopharm Therapeutics Inc. (KPTI). The current snapshot covers public activity from Mar 4, 2025 to May 15, 2026. Reported amounts are shown as $504 to $1.6K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
History Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $35250 shares | SellJan 28, 2026 | $7.03 | $9.51 | |
| $1.6k265 shares | SellJan 21, 2026 | $5.96 | $9.51 | |
| $2.3k362 shares | SellOct 1, 2025 | $6.30 | $9.51 | |
| $14823 shares | SellSep 15, 2025 | $6.43 | $9.51 | |
| $8112 shares | SellSep 3, 2025 | $6.78 | $9.51 | |
| $952238 shares | SellJul 22, 2025 | $4.00 | $9.51 |